Program
ARO-RAGE
Also written as “ARO-RAGE Injection”.
Its studies are mostly in Asthma, led by Arrowhead Pharmaceuticals.
Furthest: phase 2, since Mar 3, 20223 company-led studies, 1 open or runningNext primary completion: Dec 2027 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals | 31 open or running | phase 2since Mar 3, 2022 | Mar 3, 2022 | Dec 2027phase 2 · NCT07241546 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 3, 2022First study: phase 2 study in AsthmaFirst studyNCT05276570 · 127 enrolled · Australia, New Zealand, Poland and more
- Sep 6, 2022Phase 1 study in AsthmaNCT05533294 · 43 enrolled · New Zealand
- Nov 17, 2025Phase 2 study in AsthmaNCT07241546 · 36 planned · Canada
Ahead
- Dec 2027Primary completion: phase 2 study in AsthmaNCT07241546
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07241546Asthma · Canada | 2 | Recruiting | Dec 2027 | 36 |
| NCT05533294Asthma · New Zealand | 1 | Completed | Feb 8, 2024 | 43 |
| NCT05276570Asthma · Australia, New Zealand, Poland and more | 2 | Completed | Apr 16, 2025 | 127 |
How it is read
Names in the registry
- “ARO-RAGE”, 2 entries
- “ARO-RAGE Injection”, 1 entry
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.